BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,895.00
-15.00 (-0.52%)
At close: Feb 13, 2026
Market Cap23.68B -9.5%
Revenue (ttm)18.65B +40.9%
Net Income-246.68M
EPS-30.17
Shares Out8.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,916
Average Volume16,434
Open2,890.00
Previous Close2,910.00
Day's Range2,830.00 - 2,905.00
52-Week Range2,830.00 - 4,390.00
Beta1.10
RSI32.58
Earnings DateMar 13, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements